
<!DOCTYPE html>
<!--[if lt IE 8]>      <html class="no-js nav theme-teal lt-ie10 lt-ie9 lt-ie8  " lang="en-us"> <![endif]-->
<!--[if IE 8]>         <html class="no-js nav theme-teal lt-ie10 lt-ie9  " lang="en-us"> <![endif]-->
<!--[if IE 9]>         <html class="no-js nav theme-teal lt-ie10  " lang="en-us"> <![endif]-->
<!--[if !IE]><!-->     <html class="no-js nav theme-teal  " lang="en-us" > <!--<![endif]-->	
    <head>
        <meta charset="utf-8" />
                		<title>CDC | TB Strategic Planning</title>
        		
        <meta name="description" content="Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, TB Strategic Planning" />        <meta name="keywords" content="tuberculosis, CDC, tb, t.b., t b, t.b, dtbe, USA, mycobacterium, division of tuberculosis elimination, tb control, prevention of tb, what is tb disease, for patients, for health professionals, medical authories, about tuberculosis, tb information, tb exposure, tb facts, tb testing, tests, diagnosis, screening, questions and answers, strategic plan" />		<meta name="viewport" content="width=device-width, initial-scale=1" />
		        <link rel="apple-touch-icon-precomposed" sizes="144x144" href="../../TemplatePackage/3.0/images/cdc-touch-icon-144x144.png" />
        <link rel="apple-touch-icon-precomposed" sizes="114x114" href="../../TemplatePackage/3.0/images/cdc-touch-icon-114x114.png" />
        <link rel="apple-touch-icon-precomposed" sizes="72x72" href="../../TemplatePackage/3.0/images/cdc-touch-icon-72x72.png" />
        <link rel="apple-touch-icon-precomposed" href="../../TemplatePackage/3.0/images/cdc-touch-icon-57x57.png" />
        <link rel="shortcut icon" href="../../TemplatePackage/3.0/images/favicon.ico" />	
		
		<meta name="robots" content="index,follow" />
		<meta property="cdc:template_version" content="3.0" />
		<meta property="cdc:content-id" content="1132735"/>
		<meta property="cdc:revision-id" content="2"/>
				<link rel="canonical" href="http://www.cdc.gov/tb/about/strategicplan.htm"/>
				<!-- Internal Release Version # 3.7 -->
                			<link rel="stylesheet" href="../../TemplatePackage/3.0/css/lib/bootstrap24.css" />
	<link rel="stylesheet" href="../../TemplatePackage/3.0/css/app.css@3.2.1.7.css" />
	<!--[if gt IE 9]><!--><!--<![endif]-->
	<!--[if IE 7]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/lib/font-awesome-ie7.css" />
	<![endif]-->
	<!--[if lt IE 9]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/ie.css" />
	<![endif]-->
	<link rel="stylesheet" media="print" href="../../TemplatePackage/3.0/css/print.css@3.2.1.7.css" />
	<script src="../../TemplatePackage/3.0/js/libs/modernizr-latest.js"></script>
	<script>
		if(!Date.now){Date.now=function now(){return new Date().getTime()}}
		var page_timing = page_timing || {};
		page_timing.page_start = Date.now();
		function $$(e){if(window.$){e()}else{setTimeout(function(){$$(e)},50)}}
		// (function(){function e(e,t){var n=e.length;while(n--){if(e[n].indexOf(t)>-1){return e[n]}}return false}var t=e(document.getElementsByTagName("html")[0].className.split(" "),"theme-");if(t){var n=document.createElement("link");n.rel="stylesheet";n.type="text/css";n.media="screen";n.href="/TemplatePackage/3.0/css/themes/"+t+".css";document.getElementsByTagName("head")[0].appendChild(n)}})();

		var settings = {}, addthis = null;
	</script>

	<meta name="application-name" content="CDC.gov"/>
	<meta property="cdc:template_version" content="3.2.1.7" />
	<meta name="msapplication-TileColor" content="#0061aa" />
	<meta name="msapplication-square70x70logo" content="/TemplatePackage/3.0/images/Win8_tile_70x70.png" />
	<meta name="msapplication-square150x150logo" content="/TemplatePackage/3.0/images/Win8_tile_150x150.png" />
	<meta name="msapplication-wide310x150logo" content="/TemplatePackage/3.0/images/Win8_tile_310x150.png" />
	<meta name="msapplication-square310x310logo" content="/TemplatePackage/3.0/images/Win8_tile_310x310.png" />
	<meta name="viewport" content="width=device-width,initial-scale=1,shrink-to-fit=no">		        




        <style type="text/css">  

</style> <script type="text/javascript">(function(H){H.id=H.id.replace('no-','')})(document.documentElement)</script>        
	<link rel="stylesheet" type="text/css" href="../local/b/css/local.css"/>
  		    </head>
    <body>
				



				<div id="skipmenu">
	<a href="strategicplan.htm#searchTarget" class="skippy">Skip directly to search</a>
	<a href="strategicplan.htm#azTab" class="skippy">Skip directly to A to Z list</a>
	<a href="strategicplan.htm#nav-container" class="skippy">Skip directly to navigation</a>
	<a href="strategicplan.htm#share-bar" class="skippy">Skip directly to page options</a>
	<a href="strategicplan.htm#contentArea" class="skippy">Skip directly to site content</a>
</div>		    	<div id="wrapper">
    		
<!-- references to this removed intentionally -->
    		<header id="header">
    			<div class="container">
                    <div class="row">
                    	<div id="logo" class="span14">
                    		<!--iPad touch response and 508 voice reader issue currently under investigation -->
<a href="../../index.html" title="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People">
	<img src="../../TemplatePackage/3.0/images/masthead_subpage.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="hidden-one" />
	<img src="../../TemplatePackage/3.0/images/masthead_1-col.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="visible-one" />
</a>

<!-- IOS9 iPad bug work around - make sure screen readers have a readable version of the logo to read
<a class="tp-sr-only" href="https://www.cdc.gov">Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People</a>
 -->
                    	</div>
                    	<!-- search -->
                    	<div id="searchArea" class="span10 hidden-one hidden-two">							
							
<div class="hidden"><a href="strategicplan.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>							<div class="a2z-button pull-right hidden-one hidden-two"><a href="strategicplan.htm#" id="azTab">CDC A-Z Index <span class="icon-angle-down"></span></a></div>
                    	</div>
                    </div>
                    	<div class="hidden-three hidden-four" id="mobile-menu">
		<ul>
			<li id="vp1-menu-button" class="border-bottom-white"><a href="strategicplan.htm#" id="menu-nav"><span class="sprite-16-menu"></span>MENU</a></li>
			<li id="vp1-a2z-button" class="border-bottom-white"><a href="strategicplan.htm#" id="menu-az">CDC A-Z</a></li>
			<li id="vp1-search-button" class="border-bottom-white"><a href="strategicplan.htm#" id="menu-search"><span class="sprite-16-search-white"></span>SEARCH</a></li>
		</ul>
	</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.menu_load = Date.now(); }</script>
                    <div class="a2z-bar hide">
                    	<div>
	<ul>
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ul>
</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.a2z_load = Date.now(); }</script>                    </div>
                    <div id="searchArea-two-column" class="span24 searchbar hide hidden-three hidden-four">
						  
<div class="hidden"><a href="strategicplan.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>					</div>
                    <!--
	See the noscript include for modifying the emergency message. DO NOT add it here.
-->
<script>if (typeof page_timing !== 'undefined') { page_timing.emergency_load = Date.now(); }</script>
    				<div class="titlebar">
					 						<h2>


<a href="../default.htm">Tuberculosis (TB)</a>

</h2>
					 					</div>
    				<!-- emergency -->
<div id="emergencyContainer">
	<!--
	<div class="alert alert-error en">
		<b>Attention!</b> Uncomment this section and place the emergency message here.
	</div>
	<div class="alert alert-error esp">
		<b>&#161;Atenci&#243;n!</b> Elimine el comentario de esta secci&#243;n y colocar el mensaje de emergencia aqu&#237;.
	</div>	
	-->
</div>

<!-- no script -->
<noscript>
	<div class="alert alert-block"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../other/about_cdcgov.html">About CDC.gov</a>.</div>
</noscript>
<script>if (typeof page_timing !== 'undefined') { page_timing.noscript_load = Date.now(); }</script>
     			</div>
    		</header>
    		<div class="container">				
                <div id="content">
					<div class="row">
        				<!-- left nav -->
        				<div id="nav-container" class="hidden-one hidden-two span5">
    						<nav id="left" class="hidden-one hidden-two">
    							


<!-- begin left navigation items here -->
<h3><a href="../default.htm">Tuberculosis</a></h3>

<ul id="nav-primary">
<li><a href="../topic/basics/default.htm">Basic TB Facts</a> <!--3rd level nav-->
<ul class="selected" style=" display: block;">
<li><a href="../topic/basics/howtbspreads.htm">How TB Spreads</a></li>

<li><a href="../topic/basics/tbinfectiondisease.htm">Latent TB Infection and TB Disease</a></li>

<li><a href="../topic/basics/signsandsymptoms.htm">Signs &#38; Symptoms</a></li>

<li><a href="../topic/basics/risk.htm">TB Risk Factors</a></li>

<li><a href="../topic/basics/exposed.htm">Exposure to TB</a></li>

<li><a href="../topic/basics/tbprevention.htm">TB Prevention</a></li>

<li><a href="../topic/basics/vaccines.htm">Vaccines</a></li>

<li><a href="../topic/basics/tbhivcoinfection.htm">TB &#38; HIV Coinfection</a></li>

<li><a href="../topic/basics/glossary.htm">TB Terms</a></li>
</ul>
</li>

<li><a href="../topic/basics/personalstories.htm">Personal Stories</a>
<ul>
<li><a href="../topic/basics/deostory.htm">Deo</a></li>

<li><a href="../topic/basics/estebanstory.htm">Esteban and Danielle</a></li>

<li><a href="../topic/basics/kennistory.htm">Kenni</a></li>

<li><a href="../topic/basics/lilianastory.htm">Liliana</a></li>

<li><a href="../topic/basics/mabrukastory.htm">Mabruka</a></li>

<li><a href="../topic/basics/marthastory.htm">Martha</a></li>

<li><a href="../topic/basics/nataliestory.htm">Natalie</a></li>

<li><a href="../topic/basics/francenestory.htm">Rick and Francene</a></li>

<li><a href="../topic/basics/rosalie.htm">Rosalie and Faith</a></li>

<li><a href="../topic/basics/santosstory.htm">Santos</a></li>

<li><a href="../topic/basics/sarahstory.htm">Sarah</a></li>

<li><a href="../topic/basics/tristory.htm">Tri</a></li>
</ul>
</li>

<li><a href="../topic/testing/default.htm">Testing &#38; Diagnosis</a> <!--end 3rd level -->
<ul>
<li><a href="../topic/testing/whobetested.htm">Who Should be Tested</a></li>

<li><a href="../topic/testing/tbtesttypes.htm">Testing for TB Infection</a></li>

<li><a href="../topic/testing/testingbcgvaccinated.htm">Testing in BCG-Vaccinated Persons</a></li>

<li><a href="../topic/testing/healthcareworkers.htm">Testing Health Care Workers</a></li>

<li><a href="../topic/testing/testingduringpregnancy.htm">Testing During Pregnancy</a></li>

<li><a href="../topic/testing/diagnosingltbi.htm">Diagnosing latent TB infection and TB disease</a></li>
</ul>
</li>

<li><a href="../topic/treatment/default.htm">Treatment</a> <!--3rd level nav-->
<ul>
<li><a href="../topic/treatment/decideltbi.htm">Deciding When to Treat Latent TB Infection</a></li>

<li><a href="../topic/treatment/ltbi.htm">Treatment Regimens for Latent TB Infection (LTBI)</a></li>

<li><a href="../topic/treatment/tbdisease.htm">Treatment for TB Disease</a></li>

<li><a href="../topic/treatment/adverseevents.htm">Adverse Events</a></li>

<li><a href="../topic/treatment/tbhiv.htm">TB Treatment of Persons Living with HIV</a></li>

<li><a href="../topic/treatment/pregnancy.htm">TB Treatment and Pregnancy</a></li>

<li><a href="../topic/treatment/children.htm">TB Treatment for Children</a></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../topic/drtb/default.htm">Drug-Resistant TB</a></li>

<li><a href="../topic/research/default.htm">Research</a> <!--3rd level nav-->
<ul>
<li><a href="../topic/research/tbesc/default.htm">TB Epidemiologic Studies Consortium</a> <!--4th level nav-->
<ul>
<li><a href="../topic/research/tbesc/research_projects.htm">Research Projects</a></li>

<li><a href="../topic/research/tbesc/publications.htm">Publications</a></li>
</ul>
</li>

<li><a href="../topic/research/tbtc/default.htm">TB Trials Consortium</a> <!--4th level nav-->
<ul>
<li><a href="../topic/research/tbtc/projects.htm">Study Descriptions</a></li>

<li><a href="../topic/research/tbtc/introduction.htm">Background</a></li>
</ul>

<!--end 4th level nav--></li>

<li><a href="../topic/research/behavioral.htm">Behavioral &#38; Social Science Research</a></li>
</ul>
</li>

<li><a href="../topic/infectioncontrol/default.htm">Infection Control</a></li>

<li><a href="../topic/populations/default.htm">TB in Specific Populations</a> <!--3rd level nav-->
<ul>
<li><a href="../topic/populations/tbinafricanamericans/default.htm">African-American Community</a> <!--4th level nav-->
<ul>
<li><a href="../topic/populations/tbinafricanamericans/summit.htm">Stop TB in the African-American Community Summit</a></li>

<li><a href="../topic/populations/tbinafricanamericans/background.htm">Background</a></li>

<li><a href="../topic/populations/tbinafricanamericans/slideset/default.htm">Slideset</a></li>
</ul>
</li>

<li><a href="../topic/populations/tbinchildren/default.htm">Children</a> <!--end 4th level nav--></li>

<li><a href="../topic/populations/correctional/default.htm">Correctional Facilities</a></li>

<li><a href="../topic/populations/homelessness/default.htm">Homelessness</a></li>

<li><a href="../topic/populations/travelers/default.htm">International Travelers</a></li>

<li><a href="../topic/populations/pregnancy/default.htm">Pregnancy</a></li>

<li><a href="../topic/populations/healthdisparities/default.htm">Health Disparities</a> <!--                 <li><a href="/tb/topic/populations/disaster/default.htm">Disaster Responders</a>
                                                    
                                                        <ul>
                                                         <li><a href="/tb/topic/populations/disaster/default.htm">TB Guidance for Disaster Responders</a></li>
                                                         <li><a href="/tb/NewsandAnnoucements/earthquakes.htm">TB Guidance for Haiti Earthquake Responders</a></li>
                                                         <li><a href="/tb/NewsandAnnoucements/reliefworkerguidance.htm">Guidance for Relief Workers and Others Traveling to Haiti</a></li>
                                                       </ul>
                              </li>--><!--END ****--><!--end 4th level nav--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../topic/laboratory/default.htm">Laboratory Information</a> <!--3rd level nav-->
<ul>
<li><a href="../topic/laboratory/mpep/default.htm">Model Performance Evaluation Program (MPEP)</a></li>

<li><a href="../topic/laboratory/drug_testing.htm">Drug Susceptibility Testing</a></li>

<li><a href="../publications/guidelines/amplification_tests/default.htm">The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TB</a> <!--4th level nav-->
<ul>
<li><a href="../publications/guidelines/amplification_tests/background.htm">Background</a></li>

<li><a href="../publications/guidelines/amplification_tests/considerations.htm">General Considerations</a></li>

<li><a href="../publications/guidelines/amplification_tests/research.htm">Research Needs</a></li>

<li><a href="../publications/guidelines/amplification_tests/dst.htm">Molecular Drug Susceptibility Tests (DSTs)</a></li>

<li><a href="../publications/guidelines/amplification_tests/communication.htm">Communication Plan for New Recommendations</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/generalreccommendations.htm">General Recommendations of the Expert Panel</a></li>

<li><a href="../publications/guidelines/amplification_tests/reccomendations_acet.htm">Recommendations to ACET, CDC, DTBE</a></li>
</ul>

<!--END *****--></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/default.htm">Rapid Molecular Testing to Detect Drug-Resistant TB in the US</a> <!--4th level nav-->
<ul>
<li><a href="../topic/laboratory/rapidmoleculartesting/summary.htm">Executive Summary</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/introduction.htm">Introduction</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/background.htm">Background on Tests for Molecular Detection of DR</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/considerations.htm">General Considerations and Principles for a Molecular DR Testing Service</a>�</li>

<li><a href="../topic/laboratory/rapidmoleculartesting/scenarios.htm">Possible Scenarios and Scope of Testing for a Molecular DR Testing Service</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/researchneeds.htm">Research Needs</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/reccommendations.htm">General Recommendations of the Expert Panel</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/communication.htm">Communication Plan for the Report</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/recommendations2.htm">Recommendations</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/references.htm">References</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/panelmembers.htm">Panel Members and CDC Participants</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/appendix1.htm">Appendix 1</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/appendix2.htm">Appendix 2</a></li>

<li><a href="../topic/laboratory/rapidmoleculartesting/appendix3.htm">Appendix 3</a></li>
</ul>

<!--END *****--></li>

<li><a href="../topic/laboratory/biosafetyguidance_xdrtb.htm">Interim Laboratory Biosafety Guidance for XDR <em>Mycobacterium</em> tuberculosis strains</a></li>
</ul>
</li>

<li><a href="../statistics/default.htm">Data &#38; Statistics</a> <!--2nd level nav-->
<ul>
<li><a href="../publications/factsheets/statistics/tbtrends.htm">Trends in Tuberculosis, 2015</a></li>

<li><a href="../statistics/tbcases.htm">TB Incidence in the United States</a></li>

<li><a href="../statistics/reports/2015/default.htm">Reported TB in the US, Surveillance Report</a></li>

<li><a href="../statistics/surv/surv2015/default.htm">Tuberculosis in the United States, 2015 (Slide Set)</a></li>

<li><a href="../statistics/archived.htm">Archived Surveillance Reports and Slide Sets</a></li>
</ul>
</li>

<li><a href="../education/professionaltools.htm">Professional Resources &#38; Tools</a> <!--2nd level nav-->
<ul>
<li><a href="../education/provider_edmaterials.htm">Tools for Healthcare Providers</a></li>

<li><a href="../education/professional-resources.htm">Resources for TB Programs</a></li>
</ul>

<!--end 2nd level nav--><!-- END EDUCATION AND TRAINING--><!-- BEGIN RESOURCES FOR TB PROGRAMS--><!--1st level nav--></li>

<li><a href="../publications/default.htm">Publications &#38; Products</a>
<ul>
<li><a href="../education/patient_edmaterials.htm">Patient and Public Materials</a></li>

<li><a href="../publications/factsheets/default.htm">Fact Sheets</a> <!--3rd level nav-->
<ul>
<li><a href="../publications/factsheets/general.htm">General</a> <!--4th level nav--></li>

<li><a href="../publications/factsheets/data.htm">Data &#38; Statistics</a> <!--4th level nav--> <!-- end 4th level nav--></li>

<li><a href="../publications/factsheets/drtb.htm">Drug-Resistant TB</a> <!--4th level nav--></li>

<li><a href="../publications/factsheets/prevention.htm">Infection Control &#38; Prevention</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../publications/factsheets/specpop.htm">TB in Specific Populations</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../publications/factsheets/treatment.htm">Treatment</a></li>

<li><a href="../publications/factsheets/testing.htm">Testing &#38; Diagnosis</a> <!--4th level nav--><!-- end 4th level--></li>

<li><a href="../publications/factsheets/vaccines.htm">Vaccines &#38; Immunizations</a><!--4th level nav--></li>
</ul>
</li>

<li><a href="../publications/guidelines/default.htm">Guidelines</a> <!--3rd level nav-->
<ul>
<li><a href="../publications/guidelines/contactinvestigations.htm">Contact Investigations</a></li>

<li><a href="../publications/guidelines/control_elim.htm">Control &#38; Elimination</a></li>

<li><a href="../publications/guidelines/mdr_tb.htm">Drug-Resistant TB</a></li>

<li><a href="../publications/guidelines/genotyping.htm">Genotyping</a></li>

<li><a href="../publications/guidelines/infectioncontrol.htm">Infection Control &#38; Prevention</a></li>

<li><a href="../publications/guidelines/laboratory.htm">Laboratory</a></li>

<li><a href="../publications/guidelines/hiv_aids.htm">TB &#38; HIV</a></li>

<li><a href="../publications/guidelines/specpop.htm">TB in Specific Populations</a><!--4th level nav-->&#160;<!--END ****--><!--end 4th level nav--></li>

<li><a href="../publications/guidelines/testing.htm">Testing &#38; Diagnosis</a></li>

<li><a href="../publications/guidelines/treatment.htm">Treatment</a></li>

<li><a href="../publications/guidelines/vaccines.htm">Vaccines &#38; Immunizations</a></li>

<li><a href="../publications/guidelines/list_date.htm">Guidelines by Date</a></li>
</ul>
</li>

<li><a href="../publications/guidestoolkits/default.htm">Guides &#38; Toolkits</a> <!--3rd level nav-->
<ul>
<li><a href="../education/corecurr/index.htm">Core Curriculum</a><!--4th level nav--></li>

<li><a href="../education/ssmodules/default.htm">Self-Study Modules</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../programs/rvct/default.htm">Report of Verified Case of Tuberculosis (RVCT)</a></li>

<li><a href="../publications/guidestoolkits/forge/default.htm">Forging Partnerships to Eliminate TB</a> <!--4th level nav-->
<ul>
<li><a href="../publications/guidestoolkits/forge/toolkitword.htm">Toolkit</a></li>
</ul>

<!--end 4th level nav--></li>

<li><a href="../education/cohort.htm">Understanding the TB Cohort Review Process</a></li>

<li><a href="../publications/ltbi/default.htm">Latent Tuberculosis Infection: A Guide for Primary Health Care Providers</a></li>

<li><a href="../publications/guidestoolkits/interviewing/default.htm">Effective TB Interviewing for Contact Investigation</a></li>

<li><a href="../education/mantoux/default.htm">Mantoux Tuberculin Skin Testing Products</a></li>

<li><a href="../publications/guidestoolkits/ethnographicguides/default.htm">Ethnographic Guides</a></li>

<li><a href="../education/skillscourse/default.htm">TB Contact Investigation Interviewing Skills Course</a></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../publications/newsletters/default.htm">Newsletters</a> <!--3rd level nav-->
<ul>
<li><a href="../publications/newsletters/notes/tbn_16/tbnotes-5.htm">TB Notes, No. 5, 2016</a></li>

<li><a href="../publications/newsletters/notes/tbn_16/tbnotes-4.htm">TB Notes, No. 4, 2016</a></li>

<li><a href="../publications/newsletters/notes/tbn_16/tbnotes-3.htm">TB Notes, No. 3, 2016</a></li>

<li><a href="../publications/newsletters/notes/tbn_16/tbnotes-2.htm">TB Notes, No. 2, 2016</a></li>

<li><a href="../publications/newsletters/notes/tbn_16/tbnotes-1.htm">TB Notes, No. 1, 2016</a>&#160;<!--<li><a href="/tb/publications/newsletters/TB_Challenge/default.htm">TB Challenge</a></li>--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../publications/pamphlets/default.htm">Pamphlets, Brochures, Booklets</a> <!--3rd level nav-->
<ul>
<li><a href="../publications/faqs/default.htm">Questions and Answers</a> <!--4th level nav--></li>

<li><a href="../publications/culturalmaterials.htm">Patient Education Series</a> <!--4th level nav--> <!--end 4th level nav--></li>

<li><a href="../publications/pamphlets/getthefacts_eng.htm">Tuberculosis - Get the Facts</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../publications/pamphlets/tbandhiv_eng.htm">Tuberculosis - The Connection between TB and HIV</a> <!--4th level nav--></li>

<li><a href="../publications/pamphlets/12-doseregimen.htm">12-Dose Regimen for Latent TB Infection-Patient Education Brochure</a> <!--end 4th level nav--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../publications/posters/default.htm">Posters</a> <!--3rd level nav-->
<ul>
<li><a href="../education/mantoux/default.htm">Mantoux Tuberculin Skin Test Wall Chart</a></li>

<li><a href="../worldtbday/resources.htm">World TB Day</a></li>

<li><a href="../publications/posters/thinktb.htm">Think TB</a></li>

<li><a href="../publications/posters/stoptb.htm">Stop TB</a></li>
</ul>

<!--end 4th level nav--></li>

<li><a href="../publications/reportsarticles/default.htm">Reports &#38; Articles</a> <!--end 3rd level nav--><!--  <ul>
                       <li><a href="/tb/publications/reportsarticles/reports.htm">Reports</a>-->
<ul>
<li><a href="../publications/reportsarticles/mmwr/default.htm"><em>Morbidity and Mortality Weekly Reports (MMWRs)</em></a> <!--4th level nav--></li>

<li><a href="../publications/reportsarticles/tbarticles.htm">DTBE Authored Journal Articles</a> <!--4th level nav--><!--end 4th level nav--></li>

<li><a href="../publications/reportsarticles/labreports.htm">Tuberculosis Laboratory Aggregate Reports</a></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../publications/slidesets/default.htm">Slide Sets</a> <!--3rd level nav-->
<ul>
<li><a href="../publications/slidesets/correctionsalstaff/default.htm">The Tuberculosis (TB) in Correctional Settings</a>
<ul>
<li><a href="../publications/slidesets/correctionsalstaff/facilitatorguide.htm">Facilitator Guide</a></li>
</ul>
</li>

<li><a href="../publications/slidesets/genotyping/default.htm">Introduction to TB Genotyping</a></li>

<li><a href="../publications/slidesets/corecurr/default.htm">Core Curriculum</a> <!--4th level nav--><!-- end 4th level nav--></li>

<li><a href="../publications/slidesets/correctionalfacilities/default.htm">Epidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2014</a></li>

<li><a href="../publications/slidesets/corrections/default.htm">Prevention and Control of Tuberculosis in Correctional and Detention Facilities</a></li>

<li><a href="../publications/slidesets/infectionguidelines/default.htm">Guidelines for Preventing the Transmission of M. TB in Health care Settings</a></li>

<li><a href="../publications/slidesets/contactinv/default.htm">Investigation of Contacts of Persons with Infectious TB</a> <!--4th level nav--> <!--end 4th level nav--></li>

<li><a href="../publications/slidesets/pediatrictb/default.htm">Epidemiology of Pediatric Tuberculosis in the United States</a></li>

<li><a href="../publications/slidesets/ltbi/default.htm">Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection</a> <!--begin 4th level nav--></li>
</ul>

<!--end 3rd level nav--></li>

<li><a href="../publications/eresources.htm">Electronic Tools &#38; Resources</a> <!--3rd level nav--></li>

<li><a href="../publications/webcourseswebinars/default.htm">Web-Based Courses &#38; Webinars</a> <!--3rd level nav-->
<ul>
<li><a href="../webcourses/tb101/default.htm">TB 101 for Health Care Workers</a> <!--4th level nav-->
<ul>
<li><a href="../education/ce/tb101.htm">TB 101 CE Credits</a></li>
</ul>
</li>

<li><a href="../education/ce/interactive-corecurr.htm">Interactive Core Curriculum</a><!-- end 4th level nav--></li>

<li><a href="../programs/evaluation/default.htm">Program Evaluation</a></li>
</ul>
</li>

<li><a href="../publications/syndicated.htm">Content Syndication</a></li>

<li><a href="../publications/infographic/default.htm">Infographics</a><!--end 3rd level nav-->
<ul>
<li><a href="../publications/infographic/webresources.htm">Social Media Graphics</a></li>
</ul>
</li>
</ul>
</li>

<li><a href="../events/default.htm">Events</a></li>

<li><a href="../worldtbday/default.htm">World TB Day</a> <!--3rd level nav-->
<ul>
<li><a href="../worldtbday/resources.htm">Resources</a></li>

<li><a href="../worldtbday/championnomination.htm">U.S. TB Champions</a></li>

<li><a href="../worldtbday/2017/activities.htm">Activities</a></li>

<li><a href="../worldtbday/history.htm">History</a></li>
</ul>
</li>

<li><a href="../links/default.htm">Links</a>
<ul>
<li><a href="../links/tboffices.htm">State TB Control Offices</a></li>

<li><a href="../programs/tbwebsites.htm">TB Control Programs</a></li>
</ul>
</li>

<li><a href="default.htm">About Us</a>
<ul>
<li><a href="mission.htm">Mission Statement and Activities</a>
<ul>
<li><a href="strategicplan.htm">DTBE Strategic Plan</a></li>

<li><a href="../programs/evaluation/indicators/default.htm">National TB Program Objectives</a></li>
</ul>
</li>

<li><a href="orgchart.htm">Organization Chart</a></li>

<li><a href="advisorygroups.html">Advisory Groups</a>
<ul>
<li><a href="taskforce.htm">Federal TB Task Force</a></li>
</ul>
</li>
</ul>
</li>
</ul>


    						</nav>
    						<div class="nav-related">
							



    						


<!-- EMPTY SSI -->

							



							</div>    						    				
        				</div>
        				<div id="featureArea">
    						<div class="span19">
    							



    						</div>
        				</div>						
    					<div class="breadcrumbs hidden-one span19">
    						


<div class="bread-crumb hidden-one"></div>

    					</div>
						<div class="span19 pagetitle">	
    						    							<div class='syndicate'>
    						    						    							<div class='mSyndicate'>
    																					<h1>Division of Tuberculosis Elimination Strategic Plan 2016-2020</h1>
															    						    							</div>
    						    						    							</div>
    												</div>
						<div id="share-bar" class="span19">		
    						<div class="socialmediabar">
								<div class="row">
            						<div class="hidden-one pull-right">
        								            							            							            						</div>	
    								<div class="span8">
    									<div id="socialMediaShareContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="strategicplan.htm#"><span class="tp-sr-only">Recommend on Facebook</span><span id="share_facebook" class="facebookRecommend"> </span></a>
	 	<a class="share_button_twitter" title="Twitter" href="strategicplan.htm#"><span class="tp-sr-only">Tweet</span><span id="share_twitter" class="twitterTweet"> </span></a>
		<a class="share_button" href="strategicplan.htm#socialMediaShareContainer" ><img src="../../TemplatePackage/3.0/images/social/addthis-32.png" alt="Share" /><span class="shareButtonEn tp-sr-only" aria-label="Share">Share</span><span class="shareButtonEs tp-sr-only" aria-label="Compartir">Compartir</span></a>
	</div>
</div>

<!-- target anchor for return to top feature in VP1 -->
<a id="content-start" tabindex="-1"></a>
    								</div>
								</div>
    						</div>
    					</div>	
    					<!-- body -->
    					<div id="body" class="span19">
    						<div id="contentArea" >								
        						        																						        						                                                                                            					            					            					        							             					            					            													<a href="strategicplan.htm#" class="tp-collapsible-expand-all">Expand All <img src="../../TemplatePackage/3.0/images/plus12.png" alt="expand all" class="tp-collapsible-icon-expand"></a>
<a href="strategicplan.htm#" class="tp-collapsible-collapse-all">Collapse All <img src="../../TemplatePackage/3.0/images/minus12.png" alt="collapse all" class="tp-collapsible-icon-collapse"></a>								
        						                                                    				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible" >
		<h3>Background</h3>
		<div>
		<p><strong>Background:&#160;</strong>Tuberculosis (TB) is caused by a bacterium called <em>Mycobacterium tuberculosis</em>. The bacteria usually attack the lungs, but TB bacteria can attack any part of the body such as the kidney, spine, and brain. TB disease is almost always curable if treated promptly with the correct medications. If not treated properly, however, TB disease can be fatal. TB is spread through the air from one person to another. Not everyone infected with TB bacteria becomes sick. As a result, two TB-related conditions exist: latent TB infection and TB disease. People with latent TB infection are not infectious and cannot spread TB bacteria to others. However, if TB bacteria become active in the body and multiply, the person will go from having latent TB infection to being sick with TB disease. The lifetime risk of progressing from latent TB infection to TB disease is 5-10%.</p>

<p>Since 1953, in cooperation with state and local health departments, the United States (U.S.) national tuberculosis program has collected information on each newly reported case of tuberculosis (TB) disease in the United States. In the early 20<sup>th</sup> century, TB was the leading cause of death in the United States. From that point TB cases steadily declined until the 1980s and early 1990s when a TB resurgence occurred with over 25,000 TB cases being reported per year. The resurgence was associated with the emergence of the HIV epidemic, increased immigration from countries with high TB rates, and a deterioration of TB control programs in many jurisdictions. Following a major investment in TB control activities at all levels of government, TB cases began to decline again. In 2014, the reported number of U.S. TB cases was 9,421, with a case rate of 3.0 cases per 100,000 population (30 per million population). Since the 1992 TB resurgence peak in the United States, the number of TB cases reported annually has decreased by 65%.</p>				</div>
	</div>
	                                                                      </div>
                    </div>
                				            				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible tp-collapsible-collapsed" >
		<h3>Vision, Mission, and DTBE Strategic Framework</h3>
		<div>
		
<p><strong>Vision:</strong> Elimination of tuberculosis in the United States (defined as &#60; 1 case/million annually)</p>

<p><strong>Mission:</strong> The mission of the Division of Tuberculosis Elimination (DTBE) is to promote health and quality of life by preventing, controlling, and eventually eliminating tuberculosis in the United States.</p>

<p><strong>DTBE Strategic Framework:&#160;</strong>DTBE’s strategic plan is aligned with the <em><span class="tp-label"><a href="http://www.cdc.gov/nchhstp/strategicpriorities/docs/nchhstp-strategic-plan-through-2020-508.pdf">National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) Strategic Plan Through 2020</a></span></em>. The NCHHSTP goals are to decrease incidence of infection, decrease morbidity and mortality, and decrease health disparities. DTBE’s goal is to reduce TB morbidity in the United States with a particular focus on reducing disparities in TB morbidity among disproportionately affected groups, including foreign-born persons and racial and ethnic minorities. DTBE’s strategies, while similar to those laid out in the Center’s plan, focus on efforts unique to TB control and are aimed at eliminating TB. The six specific strategies that provide the framework for DTBE’s strategic plan are derived from the <a href="https://www.cdc.gov/tb/about/pdf/taskforcebooklet1.pdf"><span class="tp-label">U.S. government’s response</span></a><a class="noDecoration" href="http://www.cdc.gov/tb/about/pdf/taskforcebooklet1.pdf">&#160;</a> to the Institute of Medicine Report, Ending Neglect: <em>The Elimination of Tuberculosis in the United States (2000), </em>which were reaffirmed in <em><span class="cdc-decorated"><span class="tp-label"><a href="http://www.thoracic.org/advocacy/stop-tb/Eliminate_TB_USA.pdf">A Call for Action on the Tuberculosis Elimination Plan</a></span>&#160;</span> </em>published by STOP TB USA in 2010.</p>
				</div>
	</div>
	                                                                      </div>
                    </div>
                				            				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible tp-collapsible-collapsed" >
		<h3>Core Values and Guiding Principles</h3>
		<div>
		
<p>DTBE embraces the core values enumerated in NCHHSTP’s strategic plan. The core values that guide how we think and work together, how we serve our communities, how we make decisions, and how we determine our priorities include the following.</p>

<ul class=" list-bullet">
<li><strong>Accountability: </strong>Be a diligent steward of the use of funds to achieve NCHHSTP’s public health mission</li>

<li><strong>Respect: </strong>Treat persons with dignity and honesty; value diversity and differences of opinion</li>

<li><strong>Integrity: </strong>Be accurate, consistent, and honest</li>

<li><strong>Excellence: </strong>Achieve the highest standard of performance in public health science, program, and policy</li>

<li><strong>Diversity: </strong>Recruit and maintain a highly trained, inclusive, and professional workforce</li>

<li><strong>Transparency: </strong>Keep the public, partners, and staff informed about our programs, policy, and science</li>

<li><strong>Equity: </strong>Work to achieve optimal health for the populations we serve</li>

<li><strong>Innovation: </strong>Create an environment that encourages and values new ideas</li>
</ul>

<p><br />
<strong>Guiding Principles:</strong> NCHHSTP prioritizes cost-effective and scalable programs, policies, and research that will have the greatest impact on its three goals:</p>

<ol>
<li>reducing incidence of infections,</li>

<li>lowering morbidity and mortality, and</li>

<li>decreasing health disparities.</li>
</ol>

<p><br />
High impact prevention is an approach to planning and implementing activities that promotes efficient and effective use of limited resources. Accordingly, DTBE will implement programs, policies and research that:</p>

<ol>
<li>Are most cost-effective in reducing overall incidence, morbidity, mortality, and disparities in health;</li>

<li>Can be feasibly implemented at full scale with currently available resources (programs and policies should be practical to implement at the scale needed to meet the need in the target population);</li>

<li>If prioritized, will have the greatest impact on reducing incidence, morbidity, mortality, and disparities in health when implemented; and</li>

<li>Include populations that are disproportionately affected to reduce disparities by ensuring that those with the highest rates of morbidity or who are most vulnerable are effectively reached.</li>
</ol>
				</div>
	</div>
	                                                                      </div>
                    </div>
                				            				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible tp-collapsible-collapsed" >
		<h3>Challenges and Opportunities</h3>
		<div>
		
<p><strong>Challenges: </strong>As U.S. TB cases continue to decrease, the perception of TB as a public health risk diminishes as well. As a result, TB can seem to be of lower priority to the general public and many policymakers. Competition for public funds puts resources for TB control and research at risk. The greatest challenges include the following.</p>

<ul>
<li>Fewer patients with TB limits routine training opportunities in TB clinical, laboratory, research, and program efforts leading to loss of expertise and experience in TB. This loss of TB expertise and experience has resulted in decreased capacity to appropriately diagnosis, treat, manage, and prevent TB.</li>

<li>TB drugs and biologics face the same problems that threaten the supply of antibiotics in general. As demand decreases and drug patents expire, manufacturers may weigh the balance of refurbishing facilities and procuring active ingredients against the profitability of the product. Research and development of new antibiotics has not kept pace with those of other types of medicine. Therefore, periodic shortages and supply interruptions of critical TB medications have occurred in the United States over the past five years, resulting in interruptions in patient treatment, delays in treatment initiation, and potential increased community exposure to TB.</li>

<li>While numbers of TB cases decline, outbreaks are increasingly concentrated in more difficult-to-reach populations, including persons born outside the United States, racial and ethnic minorities, and people experiencing homelessness, incarceration, and substance/alcohol use. Also, TB is associated with other acute and chronic health conditions, including diabetes and HIV infection. The complexities of these social determinants and co-morbidities affects the resources required for successful prevention and control efforts.</li>

<li>Although the United States has not experienced the high numbers of drug-resistant TB reported globally, the threat of drug-resistant TB, including acquired resistance as a result of delayed diagnosis and inappropriate antibiotic treatment, continues to affect prevention and control efforts.</li>
</ul>

<p><br />
<strong>Opportunities:&#160;</strong>The decline of TB incidence could be accelerated by prioritizing TB control efforts to address disparities in TB morbidity among people in the United States who are most vulnerable to TB. These vulnerable populations include the following.</p>

<ul>
<li>Foreign-born: 65% of cases; case rate 13 times higher than U.S.-born;

<ul type="circle">
<li>In 2013, Mexico, Philippines, Vietnam, China, and India were the leading countries of origin among foreign-born U.S. TB cases;</li>
</ul>
</li>

<li>Racial/ethnic minorities: 85% of overall cases; 67% of U.S.-born cases; case rates 7-27 times higher than whites;</li>

<li>HIV infected: ~ 7% of cases;</li>

<li>Homeless: ~ 6% of all cases and ~ 18% of those with recently acquired TB;</li>

<li>Incarcerated: ~ 4% of cases;</li>

<li>Substance abuse: 7-11% of cases; and</li>

<li>Latent TB infection: Recent estimates indicate that almost 90% of U.S. TB cases result from reactivation of latent TB infection rather than recent transmission. While the U.S. reports fewer than 10,000 TB cases annually, it is estimated that up to 13 million people in the U.S. have latent TB infection. Since the study to determine this estimate did not include certain high-risk populations, such as persons experiencing homelessness or incarceration, the true burden of latent TB infection is likely greater.</li>
</ul>
				</div>
	</div>
	                                                                      </div>
                    </div>
                				            				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible tp-collapsible-collapsed" >
		<h3>Goal and Strategies</h3>
		<div>
		<p><strong>Goal: Reduce TB morbidity in the United States with a particular focus on reducing disparities in TB morbidity among disproportionately affected groups, including foreign-born persons and racial and ethnic minorities.<br />
</strong>&#160;</p>

<p><strong>Strategies:</strong></p>

<ol type="I" style=" list-style-type: upper-roman !important;">
<li><strong>Maintain control of TB:</strong> Maintain the decline in TB incidence through timely diagnosis of active TB disease, appropriate treatment and management of persons with active TB disease (both drug-susceptible and drug-resistant), investigation and appropriate evaluation and treatment of contacts of infectious TB cases, and prevention of further transmission through infection control</li>

<li><strong>Accelerate the decline:</strong> Advance toward TB elimination through targeted testing and treatment of persons with latent TB infection, appropriate regionalization of TB control activities, rapid recognition of TB transmission using DNA fingerprinting methods, and rapid outbreak response</li>

<li><strong>Develop new tools:</strong> Develop and assess new tools for the diagnosis, treatment, and prevention of TB</li>

<li><strong>Increase U.S. involvement in international TB control activities:</strong> &#160;DTBE does not have the lead in activities that directly support achievement of this goal, because it is no longer a part of DTBE’s mission, DTBE collaborates with the Division of Global HIV and Tuberculosis (proposed), the Division in CDC that is now tasked with reducing the global burden of TB. This collaboration indirectly supports DTBE’s mission because, with 65% of U.S. TB cases occurring in foreign-born persons, reductions in global TB are critical to the goal of U.S. TB elimination. Furthermore, advances made in domestic TB control may be valuable to the global effort if they can be disseminated and implemented in other settings. In this way, DTBE’s research activities (through the TB Trials Consortium and TB Epidemiologic Studies Consortium) and programmatic improvements may indirectly reduce the global TB burden.</li>

<li><strong>Mobilize and sustain support:</strong> Mobilize and sustain support for TB elimination by engaging policy and opinion leaders, health care providers, affected communities, and the public</li>

<li><strong>Track progress:</strong> Monitor progress toward the goal of TB elimination, and regularly report on progress to all partners, policy makers, and target audiences</li>
</ol>

				</div>
	</div>
	                                                                      </div>
                    </div>
                				            				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible tp-collapsible-collapsed" >
		<h3>Objectives and Targets</h3>
		<div>
		
<p><strong>Objectives and Targets:</strong></p>

<table class="table" border="0" cellpadding="0" cellspacing="0" width="100%"><thead class="primary-bg-color">
<tr>
<th>&#160;</th>
<th>2020 NTIP Target</th>
<th>NCHHSTP 2020 Target</th>
<th>DTBE Strategies</th>
</tr>

</thead><tbody>
<tr>
<td style=" width: 35%;">Reduce the incidence of TB disease</td>
<td style=" text-align: center;">1.4/100,000</td>
<td style=" text-align: center;">1.4/100,000</td>
<td style=" text-align: center;">I, II, V</td>
</tr>

<tr>
<td style=" width: 35%;">Decrease the incidence of TB disease among U.S.-born persons</td>
<td style=" text-align: center;"><span style=" font-size: 11.0pt; line-height: 115%; font-family: Calibri,sans-serif; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Times New Roman; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: Arial; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">0.4/100,000</span></td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II, V</td>
</tr>

<tr>
<td style=" width: 35%;">Decrease the incidence of TB disease among foreign-born persons</td>
<td style=" text-align: center;">11.1/100,000</td>
<td style=" text-align: center;">11.1/100,000</td>
<td style=" text-align: center;">I, II, V</td>
</tr>

<tr>
<td style=" width: 35%;">Decrease the incidence of TB disease among U.S.-born<br />
non-Hispanic blacks or African Americans</td>
<td width="20%" style=" text-align: center;">1.5/100,000</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I, II, V</td>
</tr>

<tr>
<td style=" width: 35%;">Decrease the incidence of TB disease among children younger than 5 years of age</td>
<td style=" text-align: center;">0.3/100,000</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II, V</td>
</tr>

<tr>
<td style=" width: 35%;">Increase the proportion of TB patients who have a positive or negative HIV test result reported</td>
<td width="20%" style=" text-align: center;">98%</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I</td>
</tr>

<thead class="primary-bg-color">
<tr>
<th style=" width: 35%;">&#160;</th>
<th>2020 NTIP Target</th>
<th>NCHHSTP 2020 Target</th>
<th style=" vertical-align: middle;">Supports Strategies</th>
</tr>

</thead>
<tr>
<td style=" width: 35%;">For TB patients with positive acid-fast bacillus (AFB) sputum-smear results, increase the proportion who initiated treatment within 7 days of specimen collection</td>
<td style=" text-align: center;">97%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For patients whose diagnosis is likely to be TB disease, increase the proportion who are started on the recommended initial 4-drug regimen</td>
<td style=" text-align: center;">97%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For TB patients ages 12 years or older with a pleural or<br />
respiratory site of disease, increase the proportion who have a sputum culture result reported</td>
<td width="20%" style=" text-align: center;">98%</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I</td>
</tr>

<tr>
<td style=" width: 35%;">For TB patients with positive sputum culture results, increase the proportion who have documented conversion to negative results within 60 days of treatment initiation</td>
<td style=" text-align: center;">73%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I</td>
</tr>

<tr>
<td style=" width: 35%;">For patients with newly diagnosed TB disease for whom 12 months or less of treatment is indicated, increase the proportion who complete treatment within 12 months</td>
<td style=" text-align: center;">95%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I</td>
</tr>

<tr>
<td style=" width: 35%;">For TB patients with positive AFB sputum-smear results, increase the proportion who have contacts elicited</td>
<td style=" text-align: center;">100%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For contacts to sputum AFB smear-positive TB cases, increase the proportion who are examined for infection and disease</td>
<td style=" text-align: center;">93%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For contacts to sputum AFB smear-positive TB cases diagnosed with latent TB infection, increase the proportion who start treatment</td>
<td style=" text-align: center;">91%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II</td>
</tr>

<thead class="primary-bg-color">
<tr>
<th style=" width: 35%;">&#160;</th>
<th>2020 NTIP Target</th>
<th>NCHHSTP 2020 Target</th>
<th style=" vertical-align: middle;">DTBE Strategies</th>
</tr>

</thead>
<tr>
<td style=" width: 35%;">For contacts to sputum AFB smear-positive TB cases who have started treatment for latent TB infection, increase the proportion who complete treatment</td>
<td style=" text-align: center;">81%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For TB patients with cultures of respiratory specimens identified with M. tuberculosis complex (MTBC), increase the proportion reported by the laboratory within 25 days from the date the specimen was collected</td>
<td style=" text-align: center;">78%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I</td>
</tr>

<tr>
<td style=" width: 35%;">For TB patients with respiratory specimens positive for MTBC by nucleic acid amplification (NAA), increase the proportion reported by the laboratory within 6 days from the date the specimen was collected</td>
<td style=" text-align: center;">92%</td>
<td style=" text-align: center;">--</td>
<td style=" text-align: center;">I</td>
</tr>

<tr>
<td style=" width: 35%;">Increase the proportion of culture-confirmed TB patients with a positive nucleic acid amplification test (NAAT) result reported within 2 days of specimen collection</td>
<td style=" text-align: center; height: 23px;">--</td>
<td style=" text-align: center; height: 23px;">--</td>
<td style=" text-align: center;">I</td>
</tr>

<tr>
<td style=" width: 35%;">For TB patients with positive culture results, increase the proportion who have initial drug-susceptibility results reported</td>
<td width="20%" style=" text-align: center; height: 19px;">100%</td>
<td width="20%" style=" text-align: center; height: 19px;">--</td>
<td width="20%" style=" text-align: center;">I</td>
</tr>

<tr>
<td style=" width: 35%;">For TB patients with a positive culture result, increase the proportion who have a MTBC genotyping result reported</td>
<td width="20%" style=" text-align: center;">100%</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For immigrants and refugees with abnormal chest radiographs (X-rays) read overseas as consistent with TB, increase the proportion who initiate a medical examination within 30 days of notification</td>
<td width="20%" style=" text-align: center;">84%</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I, II</td>
</tr>

<thead class="primary-bg-color">
<tr>
<th style=" width: 35%;">&#160;</th>
<th>2020 NTIP Target</th>
<th>NCHHSTP 2020 Target</th>
<th style=" vertical-align: middle;">DTBE Strategies</th>
</tr>

</thead>
<tr>
<td style=" width: 35%;">For immigrants and refugees with abnormal chest X-rays read overseas as consistent with TB, increase the proportion who complete a medical examination within 90 days of notification</td>
<td width="20%" style=" text-align: center;">76%</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For immigrants and refugees with abnormal chest X-rays read overseas as consistent with TB who are diagnosed with latent TB infection or have radiographic findings consistent with prior pulmonary TB (ATS/CDC Class 4) on the basis of examination in the U.S., for whom treatment was recommended, increase the proportion who start treatment</td>
<td width="20%" style=" text-align: center;">93%</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I, II</td>
</tr>

<tr>
<td style=" width: 35%;">For immigrants and refugees with abnormal chest X-rays read overseas as consistent with TB who are diagnosed with latent TB infection or have radiographic findings consistent with prior pulmonary TB (ATS/CDC Class 4) on the basis of examination in the U.S., and who have started on treatment, increase the proportion who complete treatment</td>
<td width="20%" style=" text-align: center;">83%</td>
<td width="20%" style=" text-align: center;">--</td>
<td width="20%" style=" text-align: center;">I, II</td>
</tr>

</tbody></table>
				</div>
	</div>
	                                                                      </div>
                    </div>
                				            				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible tp-collapsible-collapsed" >
		<h3>DTBE Activities</h3>
		<div>
		
<p><strong>Activities: DTBE activities support the <span class="tp-label"><a href="http://www.cdc.gov/nchhstp/docs/NCHHSTP-Strategic-Plan-through-2020-508.pdf">NCHHSTP Strategic Plan</a></span><a class="noDecoration" href="http://www.cdc.gov/nchhstp/docs/NCHHSTP-Strategic-Plan-through-2020-508.pdf">&#160;</a></strong></p>

<p>Specifically, to fulfill our mission and implement our strategies for TB Elimination, DTBE carries out the following:</p>

<ol>
<li>Conducts routine surveillance (including drug susceptibility), outbreak detection and surveillance, and specialized periodic surveys<br />
Supports strategies: I, II, VI<br />
Examples: National Tuberculosis Surveillance System (NTSS), Tuberculosis Genotyping Information System (TB GIMS), Aggregate Reports on Program Evaluation (ARPE), tuberculosis infection prevalence component of the National Health and Nutrition Examination Survey (NHANES), Large Outbreaks of Tuberculosis Surveillance (LOTUS)</li>

<li>Provides funding and embedded staff to state and local TB programs to support case finding and reporting, completion of treatment, contact investigation, and targeted testing and treatment of latent TB infection<br />
Supports strategies: I, II, VI<br />
Examples: Funding Opportunity Announcement for Tuberculosis Elimination and Laboratory Cooperative Agreement, DTBE public health advisors and medical officers assigned to state and local TB programs, specific initiative to address latent TB infection testing and treatment in at-risk populations</li>

<li>Supports expert medical care through funding expert medical consultation<br />
Supports strategies: I, II<br />
Examples: Regional Training and Medical Consultation Centers (RTMCCs)</li>

<li>Guides preparedness and provides programmatic consultation, technical assistance, and outbreak response assistance to state and local health departments<br />
Supports strategies: I, II<br />
Examples: DTBE Outbreak Response Plan, Outbreak Evaluation Unit, TB Epi-Aids and onsite and distance technical assistance from program consultants and other subject matter experts</li>

<li>Conducts program evaluation to improve programs<br />
Supports strategy: VI<br />
Examples: National TB Indicators Project (NTIP), program evaluation component of Tuberculosis Elimination and Laboratory Cooperative Agreement, Tuberculosis Program Evaluation Network (TB-PEN)</li>

<li>Provides laboratory diagnostic services; builds and maintains laboratory capacity<br />
Supports strategies: I, II, III<br />
Examples: National TB Reference Laboratory, laboratory capacity building through Tuberculosis Elimination and Laboratory Cooperative Agreement, Cooperative Agreement support to Association of Public Health Laboratories, National TB Laboratory Center of Excellence, national TB genotyping contract, Molecular Detection of Drug Resistance Service</li>

<li>Conducts critical, programmatically relevant behavioral, epidemiological, clinical, laboratory, and operational research to develop and evaluate new tools and interventions for diagnosis, treatment, prevention, and control of TB (to help programs work more effectively and more efficiently)<br />
Supports strategy: III<br />
Examples: Tuberculosis Trials Consortium (TBTC), Tuberculosis Epidemiologic Studies Consortium (TBESC), Laboratory Applied Research Team work on whole genome sequencing for outbreak detection, improving molecular detection of drug resistance and TB immunology</li>

<li>Provides data management; statistical, economic and epidemiologic modeling; and information technology support<br />
Supports strategies: I, II, III, IV, VI<br />
Examples: Data management and statistical support for NTSS, TB GIMS, TBTC, TBESC, economic and epidemiologic modeling activities, including those through NCHHSTP modeling cooperative agreement</li>

<li>Supports intramural infrastructure (salaries, travel, equipment, and supplies) required for maintaining subject matter experts in TB<br />
Supports strategies: I, II, III, VI<br />
Examples: DTBE program consultants and other public health advisors, medical officers, epidemiologists, scientists, statisticians, laboratorians, administrative staff, and infrastructure needed to support their work</li>

<li>Obtains external expert consultation and advice to ensure that research and program activities are responsive to emergent public health concerns<br />
Supports strategies: I, II, V, VI<br />
Examples: Advisory Council for the Elimination of TB (ACET), Office of Infectious Diseases Board of Scientific Counselors, ad-hoc consultations</li>

<li>Develops and evaluates evidence-based training and educational materials, policies, and guidelines to ensure competency in TB diagnosis, treatment, laboratory capacity, and programmatic prevention and control<br />
Supports strategies: I, II, III, IV, V, VI<br />
Examples: TB Core Curriculum, TB Self-Study Modules, TB Program Managers’ Course, TB Laboratory Course, TB Treatment Guidelines, Interferon-gamma Release Assay Guidelines, Guidelines on Infection Control in Healthcare Settings and Correctional Facilities.</li>

<li>Develops education, risk, and media communications (web- and print-based) to aid in preparedness and public awareness of TB prevention and control issues<br />
Supports strategies: I, II, III, V<br />
Examples: Online TB Fact Sheets, DTBE internet and intranet sites, media releases and responses, talking points, Twitter account</li>

<li>Cultivates relevant external partnerships, as well as collaborates within CDC and across other federal agencies<br />
Supports strategies: I, II, III, IV, V<br />
Examples: Stop TB USA, National TB Controllers’ Association, American Thoracic Society, Infectious Diseases Society of America, American Academy of Pediatrics, the Association of Public Health Laboratories, Federal TB Task Force</li>
</ol>
				</div>
	</div>
	                                                                      </div>
                    </div>
                				            				                                                                        				                                                    <div class="row">
                                                                                <div class="span19">
                                                                
				    <div class="module-typeA tp-collapsible tp-collapsible-collapsed" >
		<h3>Overarching Tactics</h3>
		<div>
		
<p><strong>Overarching Tactics: Increase emphasis or develop new activities:</strong></p>

<p><strong>Sustain commitment</strong></p>

<ul>
<li>Build and maintain partnerships, including with other disease programs and providers</li>
</ul>

<p><br />
<strong>Make the argument: Publish additional studies on cost effectiveness, costs of treatment, and return on investments</strong></p>

<ul>
<li>Establish Economics and Program Evaluation Team within DTBE (DMSB)</li>

<li>Continue to share stories of persons affected by TB</li>

<li>Monitor cooperative agreement activities on health economics and cost effectiveness</li>
</ul>

<p><br />
<strong>Maintain basic TB control functions</strong></p>

<ul>
<li>Support case finding and treatment by epidemiologic and demographic characteristics of jurisdictions (funding formula)</li>

<li>Support jurisdictions in contact investigation practices and implementation of recommendations</li>

<li>Engage state authorities in situations where state or local TB programs are incapable of implementing practices to halt transmission among vulnerable populations</li>
</ul>

<p><br />
<strong>Expand effective latent TB infection testing and treatment</strong></p>

<ul>
<li>When U.S. Preventive Services Task Force review is complete, disseminate results among TB controllers, Centers for Medicare &#38; Medicaid Services state contacts, and Federally Qualified Health Centers (FQHCs); publish Dear Colleague letter to organizations representing private providers (ATS, ILA, IDSA); identify contacts at large HMO or insurance providers (e.g., Kaiser Permanente)</li>

<li>Increase outreach to FQHCs</li>

<li>If review does not result in a recommendation to provide latent TB infection testing at the population level (either a Grade A or B), outreach and education will be even more important, to ensure persons at risk can still be provided with access to TB screening and treatment</li>

<li>Develop messaging and other communication strategies for improving treatment initiation (and completion) for those infected who are at highest risk of progressing to TB disease</li>

<li>Champion major initiative for expanded targeted latent TB infection testing and treatment with the following components

<ul type="circle">
<li>Develop registry/surveillance system for latent TB infection</li>

<li>Scale up&#160; testing to targeted populations</li>

<li>Publish guidance on identifying persons who will benefit most from targeted testing</li>

<li>End wasteful testing of low-risk persons</li>

<li>Scale up use of interferon-gamma release assays, especially for foreign-born persons</li>

<li>Scale up use of short course latent infection treatment (e.g., 12 dose treatment for latent TB infection)</li>

<li>Develop outreach and communication tools to engage affected communities and their medical providers</li>
</ul>
</li>

<li>Develop funding opportunity for intensive targeted latent TB infection testing and treatment demonstration project</li>
</ul>

<p><br />
<strong>Maintain or increase focus on prevention of TB disease in U.S. for foreign-born persons</strong></p>

<ul>
<li>Take advantage of new diagnostics (e.g., interferon-gamma release assay) and treatment/drug regimens (12 dose treatment for latent TB infection)</li>

<li>Consider expanding TB Technical Instructions (TI) for overseas TB screening for immigration to include additional visa categories (students, temporary workers); President’s budget for FY 2016 includes funding for antimicrobial resistance, which can be directed to this effort via Division of Global Migration and Quarantine</li>
</ul>

<p><br />
<strong>Maximize impact of limited resources</strong></p>

<ul>
<li>Promote and harness scientific and technological advancement</li>

<li>Share federal policies and programs that could augment TB programs’ efforts; for example, some programs already use 340B program for discounted drug purchases, some use Medicaid Section 1115 waivers, some have adopted TB Medicaid Option, and others making advances under Affordable Care Act</li>
</ul>
				</div>
	</div>
	                                                                      </div>
                    </div>
                				                                                						                                                                								<!-- Related Nav Area -->
								<div class="nav-related hidden-three hidden-four">
									



									


<!-- EMPTY SSI -->

								</div>
    							<!-- Persistent Content Area -->
    							<div id="content-secondary">
                                    



            						


<!-- EMPTY SSI -->

    							</div><!-- /end #content-secondary -->
    						</div><!-- /end #contentArea -->
    					</div><!-- /end body -->	
					</div>
					<div class="row">
						<div class="span24 visible-one">
																											</div>
					</div>
					<div class="row">
						<div class="span24">
                            <div id="plugin-legend" class="pluginOff">
	<h5>File Formats Help:</h5><span><a href="../../Other/plugins/index.html">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</a></span>
	<ul>
		<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><span class="sprite-16-pdf">Adobe PDF file</span></a></li>
		<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><span class="sprite-16-ppt">Microsoft PowerPoint file</span></a></li>
		<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><span class="sprite-16-word">Microsoft Word file</span></a></li>
		<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><span class="sprite-16-excel">Microsoft Excel file</span></a></li>
		<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><span class="sprite-16-wmv">Audio/Video file</span></a></li>
		<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><span class="sprite-16-qt">Apple Quicktime file</span></a></li>
		<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><span class="sprite-16-rp">RealPlayer file</span></a></li>
		<li class="plugin-text"><a href="../../Other/plugins/index.html#text"><span class="sprite-16-txt">Text file</span></a></li>
		<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><span class="sprite-16-zip">Zip Archive file</span></a></li>
		<li class="plugin-sas"><a href="../../Other/plugins/index.html#sas"><span class="sprite-16-sas">SAS file</span></a></li>
		<li class="plugin-epub"><a href="../../Other/plugins/index.html#epub"><span class="sprite-16-ebook">ePub file</span></a></li>
		<li class="plugin-ris"><a href="../../Other/plugins/index.html#ris"><span class="sprite-16-ris">RIS file</span></a></li>
	</ul>
</div>
						</div>
					</div>
					<!-- date stamp -->
					<div id="datestamp" class="row" itemscope="itemscope" itemtype="http://schema.org/WebPage">
						<div class="span24">
    						<ul> 
            					            						<li class="last-reviewed">Page last reviewed: <span itemprop="lastReviewed">September 1, 2012</span></li>
            													            					            						<li class="last-updated">Page last updated: <span itemprop="dateModified">November 24, 2015</span></li>
            					        							<li class="content-source">Content source:
    									



 <ul class="noindent">
  <li class="" itemprop="sourceOrganization" itemscope="itemscope" itemtype="http://schema.org/Organization"> <a href="../../tb.1.html" itemprop="url">Division of Tuberculosis Elimination</a></li>
 </ul>


        							</li>
									



    						</ul>
						</div>
					</div>					
				</div><!-- /end #content -->
			</div><!-- /.container for content -->					
			<!-- footer -->
				<footer id="footer" class="cdcSlimFooter">
	
 <!-- include eng footerSubSocialMedia.html -->
<div class="socialMedia">
	<div class="container">
		<nav class="followcdc">
			<ul>
				<li><a href="../../Other/emailupdates.1.html"><span class="sprite-24-govd"></span><span class="tp-sr-only">Email</span></a></li>
				<li><a href="https://www.facebook.com/CDC" target="_blank"><span class="sprite-24-facebook"></span><span class="tp-sr-only">Recommend</span></a></li>
				<li><a href="https://twitter.com/CDCgov" target="_blank"><span class="sprite-24-twitter"></span><span class="tp-sr-only">Tweet</span></a></li>
				<li><a href="https://www.youtube.com/user/CDCstreamingHealth" target="_blank"><span class="sprite-24-youtube"></span><span class="tp-sr-only">YouTube</span></a></li>
				<li><a href="https://www.instagram.com/CDCgov/" target="_blank"><span class="sprite-24-instagram"></span><span class="tp-sr-only">Instagram</span></a></li>
			</ul>
		</nav>
		<nav class="cdcmedia">
			<ul>
				<li><a href="https://www2c.cdc.gov/podcasts"><span class="sprite-24-listen"></span><span class="tp-sr-only">Listen</span></a></li>
				<li><a href="../../cdctv.1.html"><span class="sprite-24-watch"></span><span class="tp-sr-only">Watch</span></a></li>
				<li><a href="https://www2c.cdc.gov/podcasts/rss.asp"><span class="sprite-24-rss"></span><span class="tp-sr-only">RSS</span></a></li>
			</ul>
		</nav>
	</div>
</div>
 <!-- /include eng footerSubSocialMedia.html -->

	<div class="container">
		<div class="cdcLinks">
			<div class="container">
				<ul>
					
<!-- include eng footerSubCdcLinks.html-->
<li>
	<nav>
		<h6 class="hidden-four hidden-three">ABOUT <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../about/default.htm">About CDC</a></li>
			<li><a href="https://jobs.cdc.gov">Jobs</a></li>
			<li><a href="../../funding.1.html">Funding</a></li>
		</ul>
	</nav>
</li>
<li>
	<nav>
		<h6 class="hidden-four hidden-three">LEGAL <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/privacy.html">Privacy</a></li>
			<li><a href="../../od/foia.1.html">FOIA</a></li>
			<li><a href="../../eeo/nofearact/index.htm">No Fear Act</a></li>
			<li><a href="https://oig.hhs.gov" class="no-link">OIG</a></li>
		</ul>
	</nav>
</li>
<!--/ include eng footerSubCdcLinks.html-->

				</ul>
			</div>
		</div>
		<div class="cdcContact">
			<div class="container">
				<ul>
					<li class="local-contact">
						
 <!-- include eng footerSubGlobalContact1.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="address" itemscope="itemscope" itemtype="https://schema.org/PostalAddress">
			<span itemprop="streetAddress">1600 Clifton Road</span>
			<span itemprop="addressLocality">Atlanta</span>,
			<span itemprop="addressRegion">GA</span>
			<span itemprop="postalCode">30329-4027</span>
			<span itemprop="addressCountry">USA</span>
		</span><br />
		<span class="value" itemprop="telephone">800-CDC-INFO (800-232-4636)</span>,
		<span class="value" itemprop="telephone">TTY: 888-232-6348</span><br />
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx" class=" default no-link">Email CDC-INFO</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact1.html -->

					</li>
					<li class="contact">
						
 <!-- include eng footerSubGlobalContact2.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.hhs.gov" class="no-link">U.S. Department of Health & Human Services</a></span>
		</span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
        	<span itemprop="url"><a href="https://www.hhs.gov/open" class="no-link">HHS/Open</a></span>
        </span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.usa.gov/" class="no-link">USA.gov</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact2.html -->

					</li>
				</ul>
			</div>
		</div>
	</div>
</footer>			<!-- /#footer -->
			<div id="totop" class="off visible-one">Top</div>
        </div>
		<script>page_timing.libs_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/libs.min.js@3.2.1.7"></script><script>page_timing.libs_end = Date.now();page_timing.core_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/core.min.js@3.2.1.7"></script><script>page_timing.core_end = Date.now();</script><!-- Start Site Settings Overrides -->
<script>
CDC.Constants.set("flexSliderVideoDomains", ['youtube.com','ytimg.com','vimeocdn.com'], 'es');
	CDC.Global.settings.includeCDCInBreadCrumbBar=true;
	CDC.Global.settings.includePageInBreadCrumbBar=true;
	CDC.Global.settings.catchJSErrors=true;
	CDC.Global.settings.enableExternalLinks=true;
	CDC.Global.settings.enableFileIcons=true;
	CDC.Global.settings.simulateMobile=true;
</script>
<!-- End Site Settings Overrides --><script>page_timing.app_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/app.min.js@3.2.1.7"></script><script>page_timing.app_end = Date.now();</script>		
		        			<!-- Begin Survey scripts -->
<script src="../../JScript/foresee/foresee-trigger.js"></script>
<script src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->
			
            <script>if (typeof page_timing !== 'undefined') { page_timing.metrics_start = Date.now(); }</script>
<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->

<!-- SiteCatalyst code version: H.21. -->
<script src="../../JScript/metrics/topic_levels.js"></script>
<script src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script>

	enquire.register(CDC.Global.selectors.vp1, function() {
		s.prop49 = 1;
	});
	enquire.register(CDC.Global.selectors.vp2, function() {
		s.prop49 = 2;
	});
	enquire.register(CDC.Global.selectors.vp3, function() {
		s.prop49 = 3;
	});
	enquire.register(CDC.Global.selectors.vp4, function() {
		s.prop49 = 4;
	});

            
            


    s.pageName=document.title;
    s.channel="NCHSTP/DTBE";
    
    siteCatalyst.setLevel1("NCHHSTP"); 
    siteCatalyst.setLevel2("DTBE");
    
    

            
                        
            s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();



if(s_code) {
	document.write(s_code);
}



if (document.location.protocol) {


	var cookieManagment = {
		getUuid : function (strPrefix) {
			strPrefix = strPrefix || "";
			var d = new Date();
			var seconds = Math.round(d.getTime() / 1000);
			return strPrefix + Math.floor((1 + Math.random()) * 0x10000).toString(16).substring(1) + "-" + seconds.toString();
		},
		setCookie : function (cname, cvalue, exdays, domain) {
			domain = domain || ".cdc.gov";
			var d = new Date();
			d.setTime(d.getTime() + (exdays*24*60*60*1000));
			var expires = "expires="+ d.toUTCString();
			document.cookie = cname + "=" + cvalue + ";" + expires + ";domain=" + domain + ";path=/";
		},
		getCookie : function (cname) {
			var name = cname + "=";
			var ca = document.cookie.split(';');
			var i = ca.length;
			while (i --) {
				var c = ca[i];
				while (c.charAt(0)==' ') {
					c = c.substring(1);
				}
				if (c.indexOf(name) == 0) {
					return c.substring(name.length,c.length);
				}
			}
			return "";
		},
		init : function () {



			var currCookieVal = cookieManagment.getCookie('cdc_s_vi');

			if (!currCookieVal.length || currCookieVal.indexOf('[CS]v1') != -1) {
				var newCookieVal = cookieManagment.getUuid('[CS]v2') + "-" + cookieManagment.getUuid('');
				cookieManagment.setCookie("cdc_s_vi", newCookieVal, 7);
				return newCookieVal;
			}
			return currCookieVal;
		}
	};


	var cdcSessionID = cookieManagment.init();

	s3 = s_gi("cdcgovvistorid");

	var sKey, override = {
		fun: "cdcgovvistorid",
		trackingServer: "cdc.112.2o7.net"
	};

	s3.visitorID = cdcSessionID;

	for (sKey in s) {
		if (s.hasOwnProperty(sKey)) {
			if (override.hasOwnProperty(sKey)) {
				s3[sKey] = override[sKey];

			} else {

			}
		}
	}
	updateVariables(s3);


	var s_code_uvid = s3.t();
	if(s_code_uvid) {
		document.write(s_code_uvid);
	}
}




</script>
<script type="text/javascript">
if(navigator.appVersion.indexOf('MSIE')>=0) { document.write(unescape('%3C')+'\!-'+'-'); }
</script>
<noscript><a href="http://www.omniture.com"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<script>if (typeof page_timing !== 'undefined') { page_timing.metrics_end = Date.now(); }</script>
				


<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
});
</script>
<!--<![endif]-->

    	



						    </body>
	</html>
